Germany will become the first EU country to use antibody cocktails to fight COVID-19.
Two hundred thousand "monoclonal antibody therapies" developed by U.S. pharmaceutical giants Eli Lilly and Regeneron are being delivered to hospitals and clinics across the country this week.
The drugs have not yet been approved for COVID-19 treatment by the European Medicines Agency – but U.S. regulators at the Food and Drug Administration authorized its emergency use in November.
Antibody therapy was part of a COVID-19 "super cocktail" that also included steroids and antivirals and was administered to former U.S. President Donald Trump when he was hospitalized with the virus.
🔴 Subscribe to CGTN Europe Youtube channel for all the latest on Business, Technology, Environment and Current Affairs
🔴 Follow CGTN Europe on social media 👇🏼